{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:44:24Z","timestamp":1785451464692,"version":"3.56.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study analyzed neuropsychiatric adverse drug events (ADEs) associated with cetirizine and levocetirizine using data from the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases to inform safer clinical use for different age and gender groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed disproportionality analyses (ROR, PRR, BCPNN, MGPS) using data from the FAERS (Q1 2004 to Q3 2025) and the EudraVigilance database (January 2002 to December 2025). In addition, stratified analysis was conducted for the top 20 reported ADEs across different sex and age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Somnolence, dizziness, headache, and insomnia are common adverse drug reactions (ADRs) with high disproportionality signals for both cetirizine and levocetirizine. Cetirizine was generally associated with higher signal intensities for depression, anxiety, and drug abuse\/dependence compared to levocetirizine, with unique reports of cognitive impairment and migraine. In contrast, levocetirizine showed stronger signals not only for sleep-related ADRs but also for serious psychiatric events, including suicide attempts and suicidal ideation. Among levocetirizine users, febrile convulsions were more frequently reported in males. Additionally, pediatric patients exposed to levocetirizine were reported to have febrile convulsion and epilepsy. In the elderly, reports associated with cetirizine included subarachnoid hemorrhage, transient ischemic attack, and carotid artery occlusion, while those for levocetirizine included hepatic encephalopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the distinct neuropsychiatric risk profiles associated with cetirizine and levocetirizine. This underscores the importance of age- and sex-informed drug selection to optimize their safe use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1737359","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:27Z","timestamp":1767940707000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Gender and age variations in neuropsychiatric adverse events of cetirizine and levocetirizine: a disproportionality analysis of ICSRs from FAERS and EudraVigilance data"],"prefix":"10.3389","volume":"16","author":[{"given":"Tingting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueliang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"31280","DOI":"10.1038\/s41598-024-82684-1","article-title":"Age-specific vulnerability and high prevalence of delirium in pediatric intensive care based on a prospective cohort study","volume":"14","author":"AlDaithan","year":"2024","journal-title":"Sci. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/children10081301","article-title":"Evaluation of neuropsychiatric effects of Montelukast-Levocetirizine combination therapy in children with asthma and allergic rhinitis","volume":"10","author":"Alta\u015f","year":"2023","journal-title":"Child. (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41583-021-00513-0","article-title":"Sex differences in anxiety and depression: circuits and mechanisms","volume":"22","author":"Bangasser","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/ph16111542","article-title":"Insight into risk factors, pharmacogenetics\/genomics, and management of adverse drug reactions in elderly: a narrative review","volume":"16","author":"Bellanca","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.waojou.2021.100594","article-title":"Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: a real-world analysis of the food and drug administration (FDA) adverse event reporting system (FAERS)","volume":"14","author":"Bian","year":"2021","journal-title":"World Allergy Organ J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1152\/jn.00263.2010","article-title":"Imidazoleacetic acid-ribotide induces depression of synaptic responses in hippocampus through activation of imidazoline receptors","volume":"105","author":"Bozdagi","year":"2011","journal-title":"J. Neurophysiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1472-8206.2002.00111.x","article-title":"Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans","volume":"16","author":"Bree","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","article-title":"Using MedDRA: implications for risk management","volume":"27","author":"Brown","year":"2004","journal-title":"Drug Saf."},{"key":"B9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0301-0082(00)00039-3","article-title":"The physiology of brain histamine","volume":"63","author":"Brown","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2174\/092986708785747625","article-title":"Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine","volume":"15","author":"Chen","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40248-019-0203-6","article-title":"Focus on the cetirizine use in clinical practice: a reappraisal 30 years later","volume":"14","author":"Corsico","year":"2019","journal-title":"Multidiscip. Respir. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","article-title":"Prescribing medicines to older people-how to consider the impact of ageing on human organ and body functions","volume":"86","author":"Drenth-van Maanen","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.3390\/jcm12103566","article-title":"Migraine, allergy, and histamine: is there a link?","volume":"12","author":"Ferretti","year":"2023","journal-title":"J. Clin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/s1054-139x(94)90628-9","article-title":"Gender differences in human pharmacokinetics and pharmacodynamics","volume":"15","author":"Fletcher","year":"1994","journal-title":"J. Adolesc. Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1124\/mol.61.2.391","article-title":"Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194)","volume":"61","author":"Gillard","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fncel.2019.00433","article-title":"Subtle brain developmental abnormalities in the pathogenesis of juvenile myoclonic epilepsy","volume":"13","author":"Gilsoul","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1185\/0300799019117011","article-title":"The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare","volume":"17","author":"Hindmarch","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40360-024-00822-x","article-title":"Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders","volume":"25","author":"Hu","year":"2024","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5664\/jcsm.8794","article-title":"A case report of sleep terrors exacerbated by cetirizine","volume":"17","author":"Hussain","year":"2021","journal-title":"J. Clin. Sleep. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.18176\/jiaci.0649","article-title":"Efficacy and safety of Up-dosing antihistamines in chronic spontaneous urticaria: a systematic review of the literature","volume":"31","author":"Iriarte Sot\u00e9s","year":"2021","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jad.2023.11.025","article-title":"Safety assessment of brexpiprazole: real-World adverse event analysis from the FAERS database","volume":"346","author":"Jiang","year":"2024","journal-title":"J. Affect Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1749-6632.1989.tb22626.x","article-title":"Polyunsaturated fatty acids, prostaglandins, and schizophrenia","volume":"559","author":"van Kammen","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9146","DOI":"10.1038\/s41598-023-36415-7","article-title":"Inherent seizure susceptibility in patients with antihistamine-induced acute symptomatic seizure: a resting-state EEG analysis","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jaci.2024.11.036","article-title":"Mortality in adult patients with chronic spontaneous urticaria: a real-world cohort study","volume":"155","author":"Kolkhir","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5863\/1551-6776-19.4.262","article-title":"Developmental pharmacokinetics in pediatric populations","volume":"19","author":"Lu","year":"2014","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"116385","DOI":"10.1016\/j.socscimed.2023.116385","article-title":"A gender hypothesis of sex disparities in adverse drug events","volume":"339","author":"Lee","year":"2023","journal-title":"Soc. Sci. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8311","DOI":"10.1007\/s00210-024-03190-9","article-title":"Exploring gender differences in pharmacokinetics of central nervous system related medicines based on a systematic review approach","volume":"397","author":"Lee","year":"2024","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/exd.14602","article-title":"Pharmacogenomics for the efficacy and side effects of antihistamines","volume":"31","author":"Li","year":"2022","journal-title":"Exp. Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1113\/jphysiol.2010.193904","article-title":"Histamine regulates activities of neurons in the ventrolateral preoptic nucleus","volume":"588","author":"Liu","year":"2010","journal-title":"J. Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"H781","DOI":"10.1152\/ajpheart.00994.2013","article-title":"Why are sex and gender important to basic physiology and translational and individualized medicine?","volume":"306","author":"Miller","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1021\/acschemneuro.4c00505","article-title":"Classics in chemical neuroscience: deliriant antihistaminic drugs","volume":"15","author":"Nerush","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.2147\/dddt.S81998","article-title":"Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases","volume":"9","author":"Nomura","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/adc.2006.107516","article-title":"Outcome of convulsive status epilepticus: a review","volume":"92","author":"Novorol","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"B35","first-page":"44","article-title":"Efficacy and safety of Up-dosed second-generation antihistamines in uncontrolled chronic spontaneous urticaria: a review","volume":"16","author":"Podder","year":"2023","journal-title":"J. Clin. Aesthet. Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_21_22","article-title":"Management of medication-induced psychiatric disorders","volume":"64","author":"Raju","year":"2022","journal-title":"Indian J. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1476-5381.2010.00907.x","article-title":"Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory","volume":"161","author":"van Ruitenbeek","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jceh.2021.12.007","article-title":"Encephalopathy in cirrhosis: prevention and management","volume":"12","author":"Sahney","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA adverse event reporting system","volume":"10","author":"Sakaeda","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-016-0682-0","article-title":"Sedative effects of levocetirizine: a systematic review and meta-analysis of randomized controlled studies","volume":"77","author":"Snidvongs","year":"2017","journal-title":"Drugs"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1659852","DOI":"10.3389\/fphar.2025.1659852","article-title":"Montelukast: risk of mental disorders vs. efficacy-a meta-analysis","volume":"16","author":"Sobczak","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2024.03.032","article-title":"Therapeutic potential of natural compounds in subarachnoid haemorrhage","volume":"546","author":"Tan","year":"2024","journal-title":"Neuroscience"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/s0006-2952(03)00558-6","article-title":"Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonists","volume":"66","author":"Tillement","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.anai.2011.08.012","article-title":"Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial","volume":"107","author":"Tzanetos","year":"2011","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00003495-200161020-00006","article-title":"New insights into the second generation antihistamines","volume":"61","author":"Walsh","year":"2001","journal-title":"Drugs"},{"key":"B46","doi-asserted-by":"publisher","first-page":"864","DOI":"10.7150\/ijms.5892","article-title":"A survey of the FAERS database concerning the adverse event profiles of \u03b11-adrenoreceptor blockers for lower urinary tract symptoms","volume":"10","author":"Yoshimura","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.20.595049","article-title":"Sexual dimorphism in histamine regulation of striatal dopamine","author":"Van Zandt","year":"2025","journal-title":"bioRxiv"},{"key":"B48","doi-asserted-by":"publisher","first-page":"940213","DOI":"10.3389\/fped.2022.940213","article-title":"Cetirizine for the treatment of allergic diseases in children: a systematic review and meta-analysis","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Pediatr."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1737359\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:29Z","timestamp":1767940709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1737359\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":48,"alternative-id":["10.3389\/fphar.2025.1737359"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1737359","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1737359"}}